20/20 Biolabs, Inc. 8-K

What Happened

• 20/20 Biolabs, Inc. (AIDX) filed a Form 8-K on May 26, 2026 disclosing that its Board adopted Amendment No. 1 to the Amended and Restated Bylaws on May 19, 2026.
• The Amendment changes Section 2.5 to reduce the quorum required for a meeting of stockholders from a majority of shares outstanding to one-third of shares outstanding.

Key Details

• Board action date: May 19, 2026; 8-K filed: May 26, 2026.
• Quorum change: from a majority (>50%) to one-third (~33.33%) of outstanding shares.
• Reported under Item 3.03 (Material Modification to Rights of Security Holders) and Item 5.03 (Bylaws amendment).
• The full text of Amendment No. 1 is filed as Exhibit 3.2 to the 8-K.

Why It Matters

• This bylaw change lowers the number of shares needed to hold a valid shareholder meeting, making it easier for the company to convene meetings and conduct business when fewer shares are represented.
• For investors, a reduced quorum can affect shareholder influence over votes and corporate governance outcomes because decisions can proceed with fewer shareholders present. The filing is informational and does not itself change economic rights or report financial results.